CPA CGMA - Astrana Health Chief Officer
| ASTH Stock | 43.25 0.39 0.91% |
Executive
CPA CGMA is Chief Officer of Astrana Health
| Age | 51 |
| Address | 1668 S. Garfield Avenue, Alhambra, CA, United States, 91801 |
| Phone | 626 282 0288 |
| Web | https://www.astranahealth.com |
Astrana Health Management Efficiency
The company has return on total asset (ROA) of 0.0449 % which means that it generated a profit of $0.0449 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1026 %, meaning that it created $0.1026 on every $100 dollars invested by stockholders. Astrana Health's management efficiency ratios could be used to measure how well Astrana Health manages its routine affairs as well as how well it operates its assets and liabilities. The Astrana Health's current Return On Tangible Assets is estimated to increase to 0.11. The Astrana Health's current Return On Capital Employed is estimated to increase to 0.12. As of now, Astrana Health's Non Currrent Assets Other are increasing as compared to previous years. The Astrana Health's current Other Current Assets is estimated to increase to about 18.3 M, while Other Assets are projected to decrease to under 12.9 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Ricardo Melo | Ambev SA ADR | 52 | |
| Manuel Prieto | The Coca Cola | 57 | |
| Daniel Barsky | Fluent Inc | 68 | |
| Rodrigo Souza | Ambev SA ADR | 48 | |
| Yael Geffen | Global E Online | N/A | |
| Cosette Chaput | Dolphin Entertainment | N/A | |
| Ricardo Silva | Ambev SA ADR | 40 | |
| Jessica Batty | Fluent Inc | N/A | |
| Philip Hodges | Boston Beer | 58 | |
| Guilherme Yokaichiya | Ambev SA ADR | N/A | |
| Peng Huang | Xunlei Ltd Adr | 57 | |
| Mauricio Soufen | Ambev SA ADR | 46 | |
| Christina Ruggiero | The Coca Cola | N/A | |
| Charlene Lu | Xunlei Ltd Adr | N/A | |
| Brian Hogan | Fluent Inc | N/A | |
| Luhan Tang | Xunlei Ltd Adr | N/A | |
| Lesya Lysyj | Boston Beer | 61 | |
| Marcus Maffucci | Fluent Inc | N/A | |
| Dan Hall | Fluent Inc | N/A | |
| Yehiam Shinder | Global E Online | 43 | |
| Donald Patrick | Fluent Inc | 63 | |
Management Performance
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0449 |
Astrana Health Leadership Team
Elected by the shareholders, the Astrana Health's board of directors comprises two types of representatives: Astrana Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Astrana. The board's role is to monitor Astrana Health's management team and ensure that shareholders' interests are well served. Astrana Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Astrana Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| WaiChow MD, Chief Officer | ||
| Rita Pew, Vice Operations | ||
| Neil Ahuja, President Solutions | ||
| Kenneth MD, Executive Chairman | ||
| Carlos MD, Chief Texas | ||
| Chandan Basho, CFO COO | ||
| CPA CGMA, Chief Officer | ||
| Jeremy MD, Chief Officer | ||
| Brandon Sim, President CEO | ||
| Yubin Park, Chief Officer | ||
| Dinesh MD, Chief Officer | ||
| John Vong, Chief Officer | ||
| Rita MBA, Vice Operations | ||
| Chandan MBA, CFO COO | ||
| Brandon MS, President CEO | ||
| MPH MD, CoFounder Chairman |
Astrana Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Astrana Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0449 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 2.1 B | ||||
| Shares Outstanding | 45.65 M | ||||
| Shares Owned By Insiders | 23.69 % | ||||
| Shares Owned By Institutions | 46.00 % | ||||
| Number Of Shares Shorted | 1.56 M | ||||
| Price To Book | 2.80 X |
Currently Active Assets on Macroaxis
When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Earnings Share 1.3 | Revenue Per Share 36.415 | Quarterly Revenue Growth 0.375 | Return On Assets 0.0449 |
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Astrana Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.